Bernd Dörken Selected Research

Lymphoproliferative Disorders (Lymphoproliferative Disorder)

12/2007	Salvage therapy for relapsed posttransplant lymphoproliferative disorders (PTLD) with a second progression of PTLD after Upfront chemotherapy: the role of single-agent rituximab.
08/2007	Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.
04/2007	Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
07/2006	Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.

8	Hodgkin Disease (Hodgkin's Disease) 10/2008 - 04/2002
5	Neoplasms (Cancer) 09/2006 - 06/2002
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2007 - 07/2006
3	Colorectal Neoplasms (Colorectal Cancer) 01/2007 - 06/2002
3	Carcinoma (Carcinomatosis) 06/2005 - 04/2003
2	Multiple Myeloma 10/2005 - 05/2003
2	Breast Neoplasms (Breast Cancer) 08/2003 - 05/2002
1	Primary Effusion Lymphoma 05/2007
1	Neoplasm Metastasis (Metastasis) 01/2007
1	Rectal Neoplasms (Rectal Cancer) 09/2006
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2005
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2005
1	Myeloid Leukemia (Leukemia, Myelocytic) 05/2005
1	Glioblastoma (Glioblastoma Multiforme) 03/2005
1	Adenocarcinoma 01/2005
1	Wilms Tumor (Wilm's Tumor) 12/2004
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2004
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2002
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2002
1	Melanoma (Melanoma, Malignant) 05/2002
1	Genomic Instability 05/2002

3	rituximab (Mabthera)FDA Link 12/2007 - 04/2007
3	Fluorouracil (Carac)FDA LinkGeneric 09/2006 - 08/2003
3	NF-kappa B (NF-kB)IBA 12/2005 - 08/2002
3	imatinib (Gleevec)FDA Link 03/2005 - 10/2002
2	Transcription Factors (Transcription Factor)IBA 05/2007 - 02/2006
2	AntigensIBA 01/2005 - 06/2003
2	Immunoglobulins (Immunoglobulin)IBA 01/2004 - 04/2002
1	interleukin-21 (interleukin 21)IBA 10/2008
1	cetuximab (Erbitux)FDA Link 01/2007
1	Leucovorin (Folinic Acid)FDA LinkGeneric 09/2006
1	Activating Transcription Factor 3IBA 03/2006
1	Proteins (Proteins, Gene)IBA 02/2006
1	Sirolimus (Rapamycin)FDA Link 09/2005
1	CCAAT-Enhancer-Binding Protein-betaIBA 09/2005
1	everolimusIBA 09/2005
1	One-Step dentin bonding system (One-Step)IBA 08/2005
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 06/2005
1	decitabine (5-aza-2'-deoxycytidine)FDA Link 05/2005
1	docetaxel (Taxotere)FDA Link 01/2005
1	Cisplatin (Platino)FDA LinkGeneric 01/2005
1	Epirubicin (Ellence)FDA LinkGeneric 01/2005
1	Cytochromes c (Cytochrome c)IBA 06/2004
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2004
1	Immunoglobulin M (IgM)IBA 01/2004
1	oxaliplatin (Eloxatin)FDA Link 08/2003
1	COPP protocol (COPP)IBA 06/2003
1	Chemokine CCL3IBA 05/2003
1	STAT5 Transcription FactorIBA 09/2002
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 06/2002
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2002
1	Interleukin-7 (Interleukin 7)IBA 06/2002
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2002
1	DNA (Deoxyribonucleic Acid)IBA 05/2002

5	Drug Therapy (Chemotherapy) 12/2007 - 06/2003
2	Organ Transplantation 08/2007 - 07/2006
1	Salvage Therapy 12/2007
1	Transplantation (Transplant Recipients) 08/2007
1	Aftercare (After-Treatment) 04/2007
1	Adjuvant Chemotherapy 09/2006
1	Immunotherapy 10/2005
1	Photopheresis 08/2004